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Abstract
Background: Apathy is frequently observed in numerous neurological disorders, including Alzheimer’s and
Parkinson’s, as well as neuropsychiatric disorders including schizophrenia. Apathy is defined as a lack of motivation
characterized by diminished goal-oriented behavior and self-initiated activity. This study evaluated a chronic
restraint stress (CRS) protocol in modeling apathetic behavior, and determined whether administration of an
anticholinesterase had utility in attenuating CRS-induced phenotypes.
Methods: We assessed behavior as well as regional neuronal activity patterns using FosB immunohistochemistry
after exposure to CRS for 6 h/d for a minimum of 21 d. Based on our FosB findings and recent clinical trials, we
administered an anticholinesterase to evaluate attenuation of CRS-induced phenotypes.
Results: CRS resulted in behaviors that reflect motivational loss and diminished emotional responsiveness. CRS-
exposed mice showed differences in FosB accumulation, including changes in the cholinergic basal forebrain
system. Facilitating cholinergic signaling ameliorated CRS-induced deficits in initiation and motivational drive and
rescued immediate early gene activation in the medial septum and nucleus accumbens.
Conclusions: Some CRS protocols may be useful for studying deficits in motivation and apathetic behavior.
Amelioration of CRS-induced behaviors with an anticholinesterase supports a role for the cholinergic system in
remediation of deficits in motivational drive.
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Background
Apathy is characterized by severe loss of motivation to
participate in activities, social withdrawal and emotional
indifference [1]. Apathy shares some overlapping fea-
tures with depression, but can be distinguished by lack
of dysphoric symptoms including sadness, hopelessness
and guilt [2,3]. Apathy is a frequent neuropsychiatric
syndrome affecting up to 92% of individuals diagnosed
with Alzheimer’s disease (AD) [4-6], and up to 70% of
those with Parkinson’s disease (PD) [2,7-10]. Despite its
prevalence, relatively little is known about the underly-
ing neuropathology [10]. Stress exposure is an estab-
lished risk factor for development of neuropsychiatric
symptoms [11-14], and it has been established that ani-
mal models of chronic stress cause behavioral changes
similar to symptoms of depression in humans [15].
Exposure to extreme forms of chronic stress, including
time spent in prisoner of war and concentration camps
as well as survival of the atomic bombing, has been
documented to result in an apathetic syndrome[16-19].
For example, prisoners of the Korean War have been
described as having a reactive syndrome that included
extreme withdrawal of involvement and a paucity of
emotion, which could not be explained by depression or
psychosis, but was best characterized as “apathy” [16].
Visual observation of routine animal behavior led us to
hypothesize that a 6 hr/d/> 21 d chronic restraint stress
(CRS) protocol could be useful for modeling features of
apathy. The objectives of the study were to 1) character-
ize the loss of motivation and initiative in CRS-exposed
animals, 2) map long-term changes in neuronal activity
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itating the cholinergic system could ameliorate CRS-
induced phenotypes.
Methods
Animals
We used adult (8 wk) male C57BL/6J mice (Jackson
Laboratories, Bar Harbor, ME, USA) that were double-
housed in a standard mouse cage containing a metal
divider splitting the cage into two separate compart-
ments; each mouse retains an individual feeding com-
partment and water bottle. Mice were maintained under
a 12:12 hour light-dark cycle (6:00 AM to 6:00 PM). All
procedures were performed in accordance with guide-
lines set forth by the National Institute of Mental Health
Animal Care and Use Committee in the Guide for the
Care and Use of Laboratory Animals. Figure 1 gives an
overview of the experimental design and groups used in
the studies.
Saccharin and quinine preference
21 d prior to CRS each mouse was given simultaneous
access to two, dual-ball sipper-top bottles (Ancare, Bell-
more, NY, USA): one with purified Milli-Q water and
one containing 50 mg/L saccharine (Sigma Aldrich, St.
Louis, MO, USA). Bottles were weighed and refilled
every 3 d; positions were reversed at each change to
prevent side bias. After 21 d, mice were divided into
balanced groups with mice sharing a divider cage placed
in the same experimental group. Individual animals with
saccharin preference < 65% were excluded from the
study (~3% of total animals used). For the quinine
experiment, the saccharine solution was replaced with
15 mg/L quinine hydrochloride (Sigma Aldrich, St.
Louis, MO, USA) solution for 3 d.
Restraint stress
Mice were placed in 50 mL plastic conical tubes with
holes cut at the tips to allow for unrestricted breathing
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Figure 1 Experimental design. Group 1 (n = 10 control and n = 14 CRS-exposed for saccharin preference and quinine aversion; body and
organ weight analysis performed in n = 8 for control versus CRS). Group 2 (for HCS, n = 8 control and n = 9 CRS-exposed; n = 8 control and n
= 8 CRS-exposed for TST, FST and EZM). Group 3 (n = 6 Control and CRS-exposed). Group 4 (n = 12 Control and n = 16 CRS-exposed; CRS
group further divided, n = 8 saline and n = 8 phenserine). For cFos immunohistochemistry (IHC) experiment control group further divided into n
= 6 water exposure and n = 6 urine exposure; n = 6 saline/CRS/urine exposure and n = 6 phenserine/CRS/urine exposure were analyzed.
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were restrained for 6 h/d (10:00 AM-4:00 PM). All
behavioral tests were performed before placement in
restrainers (6 AM-10 AM).
HomeCage scan
24 h after CRS, mice were placed into clean cages con-
taining 100 mL sawdust bedding with food and water.
Animals were monitored for 22 h using Sony digital
cameras and CaptureStar video capturing software with
infrared illumination during the dark phase. Automated
video analysis of home cage behaviors was performed
using HomeCageScan software (Clever Systems, Reston,
VA). Behaviors were detected by utilizing information
about the entire body of the animal, identifying animal
body parts such as head, tail, forelimbs, hind limbs,
upper/lower back, abdomen, etc., and using sequence
data to automatically recognize and analyze animal
behaviors in durations > 6 frames (30 frames/s).
Odor Habituation/Dishabituation
We used a modified version of an odor discrimination
task [20,21] to assess effects of CRS on response to an
appetitive social stimulus, i.e female estrous urine. Cot-
ton-tipped applicators were soaked with water and fas-
tened to the roof of each cage such that mice must rear
up to sniff. Duration of sniffing was measured over a
3 min presentation. This was repeated 3X, then replaced
by 1% imitation vanilla, and finally by urine from an
estrous-stage female. Contact with the applicator with
an open mouth was considered chewing, and not scored
as sniffing.
Nest building
Old nesting material was removed, and two unused
nestlets (paper-based nesting material compacted into
white squares) [2 g/each] were placed on the cage floor.
A f t e r4h ,n e s t l e tm a t e r i a lt h a th a dn o tb e e ne i t h e r
shredded or incorporated into a nest was weighed.
Tail suspension test
Mice were suspended by their tails for 6 min using a
15 cm piece of lab tape wrapped around the tip of the
tail. Sessions were videotaped and later scored by an
observer blinded to groups. Any significant movement
of the body or the limbs was considered as mobility.
Forced swim test
Transparent plexiglass cylinders, 25 cm tall × 12 cm dia-
meter were filled with 30°C water to ~21 cm so mice were
not able to touch the floor or escape. Mice were placed in
the water for 6 min, videotaped and later analyzed with
Clever Systems Forced Swim Test Scan (Clever Sys Inc.,
L e e s b u r g ,V A ,U S A ) .A tt h ee n do fe a c hs e s s i o n ,m i c e
were dried with a paper towel and returned to their home
cage. Water was replaced for each trial.
Elevated zero maze
The ring-shaped platform consisted of two walled (white
Plexiglas) sections separated by open sections of equal
length. Each mouse was placed such that it was in an
open section, directly facing a walled section. Activity
was video-tracked for 5 min and analyzed using Clever
Systems TopScan (Clever Sys Inc., Leesburg, VA, USA).
Drug treatments
Phenserine ((-)-N-phenylcarbamoyleseroline) was synthe-
sized as a water-soluble (L)-tartrate salt (> 99.9% optical
and chemical purity)[22]. CRS-exposed mice were admi-
nistered either 0.9% saline or phenserine (1 mg/kg, i.p) in
the evening after the CRS session and again in the morn-
ing, 1 h prior to behavioral experiments. Animals within
the CRS group were randomly divided into the continued
CRS group and the CRS/phenserine group.
Tissue preparation
Animals were anaesthetized under isofluorane and trans-
cardially perfused with 50 mL of 4% paraformaldehyde
(PFA) in phosphate buffered saline (PBS). Brains were
removed from the skull and postfixed overnight at 4°C in
4% PFA/PBS, then transferred to 30% sucrose/PBS for
72 h for cryopreservation. Brains were mounted on a
freezing stage (Physitemp Instruments, Inc., Clifton, NJ)
set to -25°C and coronal sections (50 μm) were cut using
a sliding microtome (Leica, Germany) and collected in
PBS containing 0.015 M sodium azide.
Immunohistochemistry
Every 6th (prefrontal cortex and brainstem) or 12th
(hypothalamus, hippocampus) section was rinsed free-
floating in PBS/0.5% Tween-20. Non-specific binding was
blocked with 3% normal goat serum for 30 min. Sections
were incubated with an anti-fos B antibody directed
against the N-terminus, which detects both the full-
length FosB as well as its truncated form, deltaFosB (sc-
48, rabbit IgG, 1:500, Santa Cruz Biotechnology, Santa
Cruz, CA) or with an anti-c-fos antibody (PC38, 1:1000,
Calbiochem) for 24 h at 4°C. Sections were rinsed in
PBS/0.5% Tween-20, incubated for 2 h at room tempera-
ture with biotinylated goat anti-rabbit secondary antibody
(Vector Laboratories, Burlingame, CA). Endogenous per-
oxidase activity was blocked using 0.3% hydrogen perox-
ide for 30 min. The HRP-DAB reaction was carried out
using an avidin/biotin peroxidase complex (VectaStain
ABC Kit, Vector Laboratories). Sections were incubated
in ABC for 1 hr and DAB-cobalt (Sigma, St. Louis MO)
for 3 min. They were then mounted on SuperFrost-Plus
treated slides (Fisher Scientific, Pittsburgh, PA), air-dried,
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with CitriSolv, and coverslipped with Permount.
Image analysis
Section images were captured using a Leica DMRB light
microscope equipped with a CoolSNAP digital camera
and IPLab software. Cell density in the hippocampal den-
tate gyrus, nucleus accumbens, and cortical areas were
analyzed using ImageJ. Cells in thalamic, hypothalamic,
and septal nuclei were manually counted by a blinded
individual. Anatomical boundaries were determined by
using the Franklin and Paxinos mouse brain atlas [23].
Statistical analysis
Data are presented as group means ± standard error of
the mean (SEM). As appropriate, Student’s t-test, one-
way ANOVA with Newman Keul’s post hoc or two-way
ANOVA with Bonferroni post hoc were performed using
GraphPad Prism 5. Statistical significance was defined as
p < 0.05.
Results
Motivational deficits following chronic stress
Animals exposed to chronic stress consistently show
deficits in the sucrose and/or saccharin preference test,
findings which have contributed to establishing these
tests as analogs of anhedonia [24-26]. A significant
decrease in saccharin preference was found in CRS-
exposed animals (n = 14) when compared to control
animals (n = 10) beginning ~17 d after CRS initiation
[ANOVA F1,311 = 17.33, P < 0.0001 for CRS treatment;
F6,311 =5 . 5 9 ,P < 0.0001 for time; F6,311 =2 . 6 3 ,P =
0.0166 for time-CRS interaction; Bonferroni post-test,
P > 0.05 at d5, d10, d17, d25 and d31, P <0 . 0 5a td 3 8
and P < 0.01 at d44] (Figure 2a). Directly following the
last measurement for saccharin preference we changed
to a 2-bottle preference test between water and mildly
bitter quinine solution (Figure 1, Group 1). As expected,
control mice avoided the quinine, while CRS-exposed
animals drank at levels close to chance [Student’s t-test,
P = 0.0012) (Figure 2b). To validate physiological mar-
kers of chronic stress we measured total body weight as
well as weights of the adrenals, thymus and testes. Body
weights of non-stressed animals (n = 8) significantly
increased over the experiment while body weights of
CRS-exposed animals (n = 8) did not [ANOVA F1,28 =
28.79, P < 0.0001 for CRS treatment; F1,28 =3 0 . 7 9 ,P <
0.0001 for time; F1,28 = 30.54, P < 0.0001 for time-CRS
interaction; Bonferroni post-test, P < 0.001 for Control
versus CRS after CRS exposure] (Figure 2c). As
expected, there was a significant increase in adrenal
weight [F7,6 = 3.097, Student’s t-test P = 0.0022] (Figure
1d) and significant decreases in both thymus [F7,7 =
2.186, Student’s t-test P < 0.0001] (Figure 2e) and testes
[F7,7 = 1.452, Student’s t-test P = 0.0001] (Figure 2f)
weight in CRS-exposed animals.
The decrease in initiative to both approach an appetitive
stimulus and avoid an aversive stimulus indicates a poten-
tial deficit in motivation. Chronic stress models have fre-
quently been used to model symptoms of anhedonia, and
these models consistently reveal related deficits in other
depressive- and anxiety-like behaviors. We tested CRS-
exposed animals (n = 8) as compared to control animals
(n = 8) in two measures of behavioral despair, the tail sus-
pension test (TST) and the forced swim test (FST). We
observed no difference in immobility times in the TST
[F7,7 = 1.385, Student’s t-test P = 0.8802] (Figure 3a), but
saw a significant decrease in immobility times in the FST
[F7,7 = 5.994, Student’s t-test P < 0.0001] (Figure 3b). This
result is likely confounded by decreased body-weights in
CRS-exposed animals (Figure 2c). We also tested CRS-
exposed animals in the elevated zero maze (EZM) where
an increase in time spent in the open portion of the maze
indicates decreased anxiety-like behavior. Control and
CRS-exposed animals spent similar amounts of times in
the open portions of the maze [F7,7 = 3.854, Student’s
t-test P = 0.1749] (Figure 3c).
Changes in home cage behavior following chronic stress
To better understand the full range of effects of CRS on
normal home cage activity, we utilized automated beha-
vioral recognition software, HomeCage Scan (CleverSys
Inc., Reston, VA, USA), to monitor home cage activity
for 22 h (Figure 1, Group2). We began recording 24 h
following CRS, and analyzed the following behaviors: rear
u p ,h a n gc u d d l e d ,d r i n k ,e a t ,g r o o m ,s l e e p ,c h e w ,t w i t c h ,
sniff, remain low and walk slowly (software definitions in
Table 1). Prior to experimentation, accuracy of the soft-
ware in analyzing all behaviors was verified and calibrated
to experienced hand-scorers.
Our analysis revealed significant differences between
control and CRS-exposed mice in total incidence as well
as in diurnal patterns of numerous behaviors. CRS-
exposed mice spent significantly less total time rearing,
hanging cuddled, sniffing and walking slowly, but showed
no difference in total time spent grooming drinking, eat-
ing, sleeping, twitching, chewing and remaining low
(Table 2). In the first 41/2 hours prior to dark cycle onset,
CRS-exposed mice spent less time rearing up (Figure 4a),
hanging cuddled (Figure 4b), sniffing (Figure 4c), remain-
ing low (Figure 4k) and walking slowly (Figure 4d). How-
ever, they spent more time drinking (Figure 4f) and resting
(Figure 4h). It should be noted that differences in behavior
between the control and CRS-exposed groups at experi-
m e n to n s e tc o u l dr e f l e c td i f f e rences in novelty response
since the cage was changed before beginning the record-
ing. As expected there was a spike in most active behaviors
(Figure 4a-d, f, g, j, k) at dark cycle initiation and a sharp
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Figure 2 CRS-exposed mice exhibit a decreased appetitive response, and fail to avoid a mildly aversive stimulus.( a) Preference ratios
for saccharin versus water in control and CRS-exposed mice in Group 1 (see Figure 1). Shaded area denotes CRS exposure. (b) Preference ratio
for quinine versus water in control and CRS-exposed mice. (c) Control animals gain significantly more weight than CRS-exposed animals over the
course of the experiment, while CRS animals do not gain a significant amount of weight and weigh significantly less than controls after CRS-
exposure. (d) Increased adrenal weight in CRS-exposed animals; presented as % of total body weight. CRS exposure leads to decreased thymus
weight. (f) CRS exposure leads to a decreased testes weight. Results here and in subsequent figures are reported as mean ± SEM; * = p < 0.05,
** = p < 0.01 and *** = p < 0.001.
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Page 5 of 14drop in inactive behaviors (Figure 4h, i) in both groups. At
this time, control and CRS-exposed animals were similar
in sniffing (Figure 4c), walking slowly (Figure 4d) and
remaining low (Figure 4k). However, the CRS-exposed
group showed lower levels of rearing (Figure 4a) and
hanging behavior (Figure 4b), but higher levels of drinking
(Figure 4f), eating (Figure 4g) and chewing (Figure 4j) dur-
ing the first ~4 hours of the dark phase. During the shift
from dark to light (hours 15-18) CRS-exposed mice spent
significantly more time resting than control mice (Figure
4h). As opposed to control mice, whose active behaviors
showed a short, final peak right at the dark to light transi-
tion, CRS-exposed animalss h o w e dn op e a ki nr e a r i n g
(Figure 4a), hanging (Figure 4b), eating (Figure 4g),
chewing (Figure 4j), walking slowly (Figure 4d), sniffing
(Figure 4c) and remaining low (Figure 4k).
To examine overall trends in behavior, we created a
behavior-array analysis grid displaying fold increases and
decreases between control and CRS-exposed mice (Fig-
ure 5). Each box represents an individual behavior and
time point within the experiment. The intensity of color
for each box represents the magnitude of behavioral
change between control and CRS-exposed mice. Overall,
CRS-exposed mice displayed significant decreases in
exploratory behaviors such as rear-up and sniff, as well
as in locomotor behaviors including walk slowly, remain
low, and hang cuddled for several hours directly prior to
the onset of the dark cycle and before the onset of the
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Figure 3 CRS-exposure does not affect depressive- and anxiety- like behavior.( a) Control and CRS-exposed animals spend a similar
amount of time immobile in the tail suspension test. (b) CRS-exposed animals spend significantly less time immobile in the FST. (c) CRS-exposed
animals do not differ in the amount of time spent in the open portion of an elevated zero maze.
Table 1 Software definitions for scoring HomeCage Scan behaviors
Behavior Software Definition
Rear Up Begins with the mouse lifting its front paws off the ground and standing on its hind legs. Rearing ends when the mouse comes
back down and places one front paw back on the ground. Rearing may also include “partially reared” in which the mouse hunches
its back and its front paws are off the ground, and is about halfway from being in the fully stretched, completely reared position.
Hang
Cuddled
Both forelimbs and hindlegs are above the midpoint between the floor and the top of the cage.
Drink Behavior starts when mouth is at level with the drinking spout. Behavior ends when mouth withdraws from the drinking spout.
Sniffing behaviors directly before drinking are scored as drinking.
Eat Snout is in the plane of the food compartment with minimal body and head movements. “Sniff” and “eat” are differentiated by the
total time the snout remains in the food bin, with “sniff” being significantly less duration in the compartment. However, if the mouse
sniffs directly before eating, the sniff behavior is scored as eating.
Groom Mouse uses front paws to clean itself by rubbing over body and face in circular movements. Repetitive paw movements over a
certain period of time are scored as groom.
Sleep A minimum of 30 s of no significant movement of the mouse while it is in a non-rearing and non-hanging position is scored as
sleep.
Twitch Any movement occurring during sleep
Sniff Body of mouse is stationary, but snout moves in a bobbing fashion. Scored as an exploratory behavior.
Remain Low Prolonged inactivity of the mouse that is not scored by the software as any other behavior.
Walk Slowly Mouse is moving across the cage and at least three legs are propelling it forward
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of non-essential activities. However, directly prior to
dark cycle onset, inactive behaviors such as twitch and
rest increased in the CRS mice.
Neuronal activity mapping
We used FosB immunohistochemistry to analyze neuronal
activity patterns in control and CRS-exposed animals. Ani-
mals were killed 24 h following the last session of CRS and
brains processed for FosB immunoreactivity (Figure 1,
Group 3). The antibody used detects both full-length FosB
as well as truncated deltaFosB, which gradually accumu-
lates due to its high stability and long half-life. A recent
report showed that in CRS-exposed rats (1 h/d/10 d), del-
taFosB is the predominant Fos family protein induced and
that the 35-37 kDa deltaFosB isoform is the only Fos
family protein that remains elevated 24 h after the final
stress exposure [27]. In agreement with a previous study
[27], CRS-exposed mice (6 hr/d/28 d) showed significant
increases in FosB immunoreactivity in the medial septum
(MS)/nucleus of the vertical limb of the diagonal band
(vDB) and the lateral septum (LS) (Table 3, Figure 6).
Differing from this study [27], we observed significant
increases in FosB immunoreactivity in hypothalamic
regions including the arcuate nuclei and the paraventricu-
lar nucleus (PVN), but no differences in the prelimbic cor-
tex (PrL), the infra-limbic cortex (IL) or the nucleus
accumbens (NAcc). The differences between our results
and those in previous studies may be explained by species
and strain differences or from differences in CRS duration
and protocol [27,28].
Effects of cholinergic facilitation on motivation and
apathetic behavior
DeltaFosB accumulation in the MS/vDB, one of the
major basal forebrain cholinergic nuclei, suggests that
this area undergoes significant changes in gene tran-
scription and neuronal activity after CRS. This data,
coupled with reports that treatment with acetylcholines-
terase inhibitors (AChE-I) leads to remediation of
apathetic behavior[10,29], led us to ask whether the
CRS-induced behavioral deficits could be rescued by
facilitating cholinergic signaling.
We administered phenserine, a centrally active and
potent AChE-I, 21 d after initiating CRS. Phenserine
was administered 2x/d/6 d in accord with its anticholi-
nesterase half-life of 8.25 h before beginning behavioral
analysis (Figure 1, Group 4) [30]. Preference ratios for
Control animals were 74.5 ± 7.2 and preference ratios
for CRS-exposed animals were 50.4 ± 4.7 prior to the
phenserine study. Saline-injected CRS-exposed animals
showed no improvement in saccharin preference, but
CRS-exposed animals administered phenserine increased
preference by ~13% over stress-induced depressed levels
[ANOVA F2,21 = 6.505, P = 0.007; Newman-Keuls Mul-
tiple Comparisons for Control vs CRS P > 0.05, for Con-
trol vs CRS/Phenserine P <0 . 0 5a n df o rC R Sv e r s u s
CRS/Phenserine P < 0.01] (Figure 7a). We next looked
at the effect of phenserine on the motivation levels of
CRS-exposed animals in a nest-building paradigm. Exist-
ing nests and nesting materials were removed, and ani-
mals were provided new nesting material. After 4 h,
unused nesting material was measured. CRS-exposed
animals showed significantly decreased motivation in
nest building as determined by incorporation of less
nestlet material, but phenserine treatment led to a
significant improvement [ANOVA F2,21 =1 1 . 0 0 ,P =
0.0001; Newman-Keuls Multiple Comparisons for Con-
trol vs CRS P < 0.001, for Control vs CRS/Phenserine
P < 0.05 and for CRS versus CRS/Phenserine P <0 . 0 5 ]
( F i g u r e7 b ) .W er u l e do u t the possibility that the
decreased nest-building could be a result of weakness in
the CRS-exposed animals by performing a wire hang
test to check for muscle strength [ANOVA F2,21 =
1.172, P = 0.3291] (Figure 7c).
To determine whether loss of motivational drive in the
saccharin preference test transfers to an alternative appeti-
tive stimulus, we measured the time spent sniffing on
urine from a female estrous mouse in a modified odor
habituation/dishabituation test. We first measured time
spent sniffing a Q-tip dipped in water upon its initial pre-
sentation and then habituation to the smell on the 2nd
and 3rd presentations. Next, we determined whether the
animal showed normal dishabituation in response to pre-
sentation of a novel vanilla scent and then habituation to
t h i ss c e n to nt h e2 n da n d3 r dp r e s e n t a t i o n s .L a s t l y ,w e
introduced female estrous urine and measured dishabitua-
tion and then habituation. Both control and CRS-exposed
mice showed normal habituation and dishabituation
curves in response to the 3 stimuli (Figure 7d). Animals
Table 2 Home-cage behavior analysis array of control
versus CRS-exposed mice
Control CRS
Behavior Mean (s) SEM Mean (s) SEM F value P value
Rear Up 81.08 9.21 28.99 4.26 3.12 < 0.0001
Hang Cuddled 268.7 18.13 118.7 25.23 2.9 0.01
Sniff 2783 230.2 1717 221.1 1.38 0.01
Walk Slowly 1918 143.4 1414 137.1 1.37 0.03
Groom 8820 771 10050 858.4 1.86 0.34
Drink 185.6 24.18 334.1 69.94 12.55 0.12
Eat 4451 503 4773 976.5 5.65 0.8
Sleep 27560 883 31670 1799 6.23 0.1
Twitch 667.2 75.62 776.3 58.71 1.11 0.27
Chew 930.4 139.9 1330 184.1 2.6 0.14
Remain Low 12120 810 11120 598.6 1.22 0.33
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Page 7 of 14exposed to CRS spent slightly less overall time sniffing on
water [ANOVA F2,21 = 4.101, P = 0.0314; Newman-Keuls
Multiple Comparisons for Control vs CRS P < 0.05, for
Control vs CRS/Phenserine P >0 . 0 5a n df o rC R Sv e r s u s
CRS/Phenserine P > 0.05] (Figure 7e), no difference in
time spent sniffing on vanilla [ANOVA F2,21 = 5.46, P =
0.0149; Newman-Keuls Multiple Comparisons for Control
vs CRS P > 0.05, for Control vs CRS/Phenserine P <0 . 0 5
and for CRS versus CRS/Phenserine P > 0.05] (Figure 7f),
and significantly less time sniffing on estrous urine
[ANOVA F2,21 = 24.03, P < 0.0001; Newman-Keuls Multi-
ple Comparisons for Control vs CRS P < 0.001, for Con-
trol vs CRS/Phenserine P < 0.01 and for CRS versus CRS/
Phenserine P < 0.01] (Figure 7g).
To better understand the brain regions phenserine may
act on to mediate its behavioral effects in CRS-exposed
animals, we used c-fos immunohistochemistry to examine
neuronal activation patterns in response to presentation of
estrous urine. For this experiment, animals were divided
into 4 groups: saline-injected/non-CRS exposed animals
t h a ts n i f f e do naQ - t i pd i p p e di n water, saline-injected/
non-CRS exposed animals that sniffed on a Q-tip dipped
in estrous urine, saline-injected/CRS exposed animals that
sniffed on a Q-tip dipped in estrous urine and phenserine-
injected/CRS-exposed animals that sniffed on Q-tip
dipped in estrous urine. Animals were allowed to sniff on
the Q-tip for 3 min and killed 2 h later for c-fos immuno-
histochemistry. In non-stressed, saline-injected animals
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Figure 4 Animals exposed to CRS show differences in the diurnal patterns of engaging in numerous home cage activities.D a t as h o w
22 h behavior plots for (a) rearing up, (b) hanging-cuddled, (c) sniffing, (d) walking slowly, (e) grooming, (f) drinking, (g) eating, (h) sleeping, (i)
twitching, (j) chewing, and (k) remaining low.
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Page 8 of 14(n = 6), sniffing on estrous urine (hatched bars) as
opposed to water (white bars) increases c-fos immunor-
eactivity in numerous brain regions including the medial
preoptic area (MPO), LS, MS, NAcc and PrL (Figure 8a, b,
c, d and 8e). CRS-exposed animals that were injected with
saline (n = 6) (black bars) did not show the increase in c-
fos immunoreactivity in the MPO, LS, MS, NAcc and PrL
(Figure 8a, b, c, d and 8e) after sniffing on estrous urine.
However, phenserine administration in CRS-exposed ani-
mals (n = 6) was capable of fully rescuing the response to
estrous in the NAcc (Figure 8d) and partially rescuing the
response in the MS (Figure 8c). ANOVA and post-hoc sta-
tistics for Figure 8 are provided in the accompanying
Table 4.
Discussion
A major objective of this study was to characterize CRS-
induced deficits in motivational drive. As expected CRS-
exposed animals lost their preference for saccharin, but
also failed to avoid a bitter quinine solution (Figure 2a, b).
A similar phenomenon has been reported in rhesus mon-
keys following maternal deprivation [31]. This study pro-
posed that in addition to producing anhedonia, some
chronic stress paradigms may decrease motivation for
appetitive stimuli in general [31]. Deficits in the sucrose
and saccharin preference tests have been reliably used as
measures of anhedonia [24-26], which is defined as the
inability to experience pleasure in previously enjoyable
activities such as eating, exercising, socializing and sex
[32-34]. The saccharin preference deficit coupled with the
lack of quinine aversion may also indicate apathy, a lack of
interest in surroundings, social withdrawal and loss of
motivation and initiative [35,36]. Apathy, on its own, or
when co-morbid with depression poses a challenge to clin-
icians due to their overlapping symptomatology and fre-
quent co-occurrence [3]. Identifying apathy requires
Figure 5 Differences in specific home cage behaviors at discrete periods within the daily cycle. Behavior-array analysis grid displaying fold
increases and decreases between control and CRS-exposed mice. Each box represents an individual behavior and time point within the
experiment. The intensity of color for each box represents the magnitude of behavioral change between control and CRS-exposed mice.
Table 3 deltaFosB immunoreactivity in control versus CRS-exposed mice
Brain Region Control CRS Fold Difference
Mean (Cells/pixel) Mean (Cells/pixel) CRS vs Control F Value P Value
Dentate Gyrus 0 0 1.2891 1.533 0.11
Nucleus Accumbens 0 0 1.4205 2.061 0.07
Prelimbic Cortex 0 0 1.4308 8.433 0.05
Infralimbic Cortex 0 0 1.0169 1.328 0.93
Cingulate Cortex 0 0 1.0033 2.134 0.99
Visual Cortex 0 0 1.1538 1.295 0.25
Mean (cells counted) Mean (cells counted)
Medial Septum/vDB 25.67 52.83 2.0580 1.794 0.01
Lateral Septum 568.7 1564 2.7501 2.510 < 0.0001
PVA 164.8 243 1.4745 2.718 0.22
PVN 34.17 125.3 3.6670 15.590 0
Arcuate 10 52.17 5.2170 12.710 0
SCN 5.83 2.5 0.4286 3.628 0.26
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Page 9 of 14differentiation between loss of initiation versus loss of abil-
ity and emotional indifference versus a primary mood dis-
turbance [7]. Modeling apathy is important since it does
not respond similarly to treatment options for anhedonia
[37,38]. Accordingly, despite their overlapping symptoma-
tology, there is accumulating evidence that apathy and
anhedonia may have different underlying alterations in
brain circuits [3,39].
We show that loss of motivational drive in CRS-exposed
animals in the saccharin preference test can transfer to a
decrease in motivation for an alternative appetitive stimu-
lus. First, we showed that CRS-exposed animals showed
normal habituation and dishabituation to three different
odors, confirming intact olfactory senses (Figure 7d).
However, we observed a significant decrease in interest for
estrous urine (Figure 7g), suggesting that these animals
exhibit deficits in motivational drive. CRS-exposed animals
also show lack of motivation in a nest-building paradigm
[35,36] and decreases in home-cage exploratory behaviors.
For example, we saw significant differences in total time
spent rearing up, hanging cuddled and sniffing (Table 2),
and in patterns of diurnal activity. Since alterations in
sleep and circadian rhythms play a critical role in the
pathophysiology of numerous neuropsychiatric disorders
[33,40,41], the ability to model circadian alterations is a
useful experimental tool.
It has been suggested that apathy may reflect an inter-
action between cholinergic deficiency and subsequent
neurological changes in limbic regions [42]. Thus, we
asked whether deltaFosB accumulation in the MS/vDB,

		 



Figure 6 Changes in deltaFosB immunoreactivity following CRS exposure. Representative image showing increased deltaFosB
immunoreactivity in the medial septum (MS) and lateral septum (LS) after exposure to CRS.
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Page 10 of 14which constitutes the major cholinergic projection to
the hippocampal formation, cingulate cortex and the
hypothalamus [29] could be influencing cholinergic sig-
naling. AChE-I treatment reduces incidence of apathy
and improves functioning in patients who present with
cholinergic disturbances in limbic and paralimbic cor-
t i c e s[ 1 0 , 2 9 ] ,a n dr e s t o r a t i o no ff u n c t i o ni nt h e s eb r a i n
regions may underlie the behavioral response to AChE-
Is [9,43]. In AD, functional loss is thought to be a con-
sequence of neuronal loss in cholinergic nuclei, and it
has previously been reported that CRS can result in hip-
pocampal atrophy [44]. However, it appears that choli-
nergic function in our model may be altered via changes
resulting from alterations in plasticity as opposed to
neuronal loss because levels of the cholinergic cell mar-
ker p75
NTR are unchanged between control and CRS-
exposed animals and there are no appreciable changes
in regional volume between control and CRS-exposed
animals (KM and RJS, unpublished observations).
It is also possible that the behavioral effects of phen-
serine in our model result from activation of cholinergic
interneurons in areas implicated in motivation and
reward. For example, it has been shown that the AChE-
Is galantamine and donepezil lead to increased dopa-
mine release in NAcc [45,46]. Control animals show a
robust increase in immediate early gene activation in
the NAcc after being exposed to a motivating stimulus,
i.e. estrous urine (Figure 8d), but this increase is lost in
CRS-exposed animals. However, phenserine administra-
tion rescued this deficit, suggesting that cholinergic
facilitation may restore dopaminergic function in the
CRS-exposed NAcc. This restorative function could
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Page 11 of 14contribute to phenserine’s role in behavioral rescue of
motivational drive in CRS-exposed animals (Figure 7a,
b, d).
The focus of the experiments with phenserine was to
determine whether an anticholinesterase had utility in
reversing selected CRS-induced phenotypes rather than
determining the effect of the drug in a naïve population.
However, it remains a caveat of our studies that our
study did not include a control group to look at the
effects of phenserine in a non-CRS exposed population.
0
5
10
15
20
25 * *
#
 
c
-
f
o
s
 
p
o
s
i
t
i
v
e
 
c
e
l
l
s
0
100
200
300 ** **
#
c
 
-
f
o
s
 
p
o
s
i
t
i
v
e
 
c
e
l
l
s
0
3
6
9
12
15
ns
* **
#
 
c
-
f
o
s
 
p
o
s
i
t
i
v
e
 
c
e
l
l
s
0
5
10
15
20
ns
* **
#
 
c
-
f
o
s
 
p
o
s
i
t
i
v
e
 
c
e
l
l
s
0
10
20
30
40
**** *
#
 
c
-
f
o
s
 
p
o
s
i
t
i
v
e
 
c
e
l
l
s
a b
c d e
saline/no stress/water
saline/no stress/urine
saline/CRS/urine
phenserine/CRS/urine
MPO LS
MS NAcc PrL
Figure 8 Treatment with the AChE-I, phenserine provides a partial recovery for CRS-induced deficits in immediate early gene
activation following exposure to a motivational stimulus.( a) Control animals (no CRS), injected with saline and exposed to a Q-tip dipped
in estrous urine (hatched bars) show significantly increased numbers of c-fos positive nuclei in the medial preoptic area (MPO) as compared to
those exposed to a Q-tip dipped in water (white bars). CRS animals administered either saline (black bars) or phenserine (grey bars) do not show
an increase in c-fos positive nuclei after sniffing on estrous urine. (b) Control animals (no CRS), injected with saline and exposed to a Q-tip
dipped in estrous urine (hatched bars) show significantly increased numbers of c-fos positive nuclei in the LS as compared to those exposed to
a Q-tip dipped in water (white bars). CRS-exposed animals administered either saline (black bars) or phenserine (grey bars) do not show an
increase in c-fos positive nuclei after sniffing on estrous urine. (c) Control animals (no CRS), injected with saline and exposed to a Q-tip dipped
in estrous urine (hatched bars) show significantly increased numbers of c-fos positive nuclei in the MS as compared to those exposed to a Q-tip
dipped in water (white bars). CRS-exposed animals administered saline (black bars) do not show an increase in c-fos positive nuclei after sniffing
on estrous urine. CRS-exposed animals administered phenserine (grey bars) partially recover the induction in c-fos positive nuclei following
estrous urine exposure. (d) Control animals (no CRS), injected with saline and exposed to a Q-tip dipped in estrous urine (hatched bars) show
significantly increased numbers of c-fos positive nuclei in the NAcc as compared to those exposed to a Q-tip dipped in water (white bars). CRS
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nuclei in the PrL as compared to those exposed to a Q-tip dipped in water (white bars). CRS animals administered either saline (black bars) or
phenserine (grey bars) do not show an increase in c-fos positive nuclei after sniffing on estrous urine.
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Page 12 of 14Thus, it is possible that the effects of phenserine may
not be limited to animals exposed to CRS, but may also
have similar effects on a control population.
Conclusions
This CRS protocol resulted in behaviors reflecting moti-
vational loss and diminished emotional responsiveness
as well as changes in deltaFos B accumulation in brain
regions that could affect normal cholinergic signaling.
Facilitating the cholinergic system results in partial res-
cue of CRS-induced impairments to initiation and moti-
vational drive. Our study provides support for further
study of utilizing AChE-Is and cholinergic mimetics in
neuropsychiatric symptoms of motivational loss and
apathetic behavior.
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